Digital Pathology Market by Product (Brightfield Scanner, Enterprise Software, Storage System), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), Indication (Onco, Hemo), End User (Pharma & Biotech, Hospital) - Global Forecast to 2031

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING MARKET
• 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 DIGITAL PATHOLOGY MARKET OVERVIEW
• 3.2 DIGITAL PATHOLOGY MARKET, BY PRODUCT & REGION
• 3.3 DIGITAL PATHOLOGY MARKET: GEOGRAPHIC SNAPSHOT

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 AI-enabled digital pathology improving laboratory throughput, workflow efficiency, and diagnostic accuracy
    • 4.2.1.2 Rising burden of cancer and other chronic diseases
    • 4.2.1.3 Expanding adoption of digital pathology in drug discovery, biomarker validation, and clinical research
    • 4.2.1.4 Growing adoption of computational pathology and advanced image analysis technologies
    • 4.2.1.5 Increasing shortage of pathologists driving laboratory digitization and workflow automation
    • 4.2.1.6 Rising adoption of telepathology and remote diagnostic workflows
    • 4.2.1.7 Growing integration of digital pathology with EHR, PACS, and laboratory information systems
    • 4.2.1.8 National cancer screening programs and healthcare digitalization initiatives
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 High initial capital investment for scanners, software platforms, and storage infrastructure
    • 4.2.2.2 Data interoperability issues with legacy laboratory and healthcare information systems
    • 4.2.2.3 Regulatory and reimbursement uncertainties across key markets
    • 4.2.2.4 Large-scale image storage, archiving, and data management requirements
    • 4.2.2.5 Limited standardization across digital pathology workflows, image formats, and deployment practices
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Growing adoption of digital biomarkers in drug development and clinical research
    • 4.2.3.2 Increasing utilization of companion diagnostics and precision oncology applications
    • 4.2.3.3 Growth of cloud-native digital pathology platforms and SaaS-based deployment models
    • 4.2.3.4 Affordable scanner development enabling adoption in low-resource settings
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Shortage of skilled pathologists and technicians
    • 4.2.4.2 Algorithm validation, explainability, and clinical trust in AI-assisted diagnostics
    • 4.2.4.3 Data privacy, cybersecurity, and patient information protection concerns
    • 4.2.4.4 Integration complexity across heterogeneous healthcare IT environments
• 4.3 UNMET NEEDS AND WHITE SPACES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF SUPPLIERS
  • 5.1.4 BARGAINING POWER OF BUYERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS AND FORECAST
  • 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
• 5.3 VALUE CHAIN ANALYSIS
  • 5.3.1 RESEARCH & PRODUCT DEVELOPMENT
  • 5.3.2 COMPONENT AND TECHNOLOGY INFRASTRUCTURE
  • 5.3.3 PLATFORM DEVELOPMENT AND INTEGRATION
  • 5.3.4 DISTRIBUTION
  • 5.3.5 MARKETING AND SALES
  • 5.3.6 POST-SALE SERVICES
• 5.4 ECOSYSTEM ANALYSIS
• 5.5 PRICING ANALYSIS
  • 5.5.1 INDICATIVE PRICING FOR DIGITAL PATHOLOGY PRODUCTS, BY KEY PLAYERS (2025)
  • 5.5.2 INDICATIVE PRICING FOR DIGITAL PATHOLOGY PRODUCTS, BY REGION (2025)
• 5.6 TRADE ANALYSIS
  • 5.6.1 IMPORT DATA (HS CODE 901180)
  • 5.6.2 EXPORT DATA (HS CODE 901180)
• 5.7 KEY CONFERENCES AND EVENTS, 2026-2027
• 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.9 INVESTMENT AND FUNDING SCENARIO
• 5.10 CASE STUDY ANALYSIS
• 5.11 IMPACT OF 2025 US TARIFF - DIGITAL PATHOLOGY MARKET
  • 5.11.1 INTRODUCTION
  • 5.11.2 KEY TARIFF RATES
  • 5.11.3 PRICE IMPACT ANALYSIS
  • 5.11.4 IMPACT ON COUNTRY/REGION
    • 5.11.4.1 US
    • 5.11.4.2 Europe
    • 5.11.4.3 Asia Pacific
  • 5.11.5 IMPACT ON END USERS
    • 5.11.5.1 Hospitals and health systems
    • 5.11.5.2 Diagnostic and reference laboratories
    • 5.11.5.3 Veterinary laboratories
    • 5.11.5.4 Pharmaceutical and biotechnology companies
    • 5.11.5.5 Contract research organizations
    • 5.11.5.6 Academic and research institutes

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 KEY EMERGING TECHNOLOGIES
  • 6.1.1 CLOUD STORAGE & ARCHIVING
  • 6.1.2 WHOLE SLIDE IMAGING (WSI) SCANNERS
  • 6.1.3 IMAGE MANAGEMENT SYSTEMS
  • 6.1.4 AI-ENABLED IMAGE ANALYSIS & COMPUTATIONAL PATHOLOGY PLATFORMS
  • 6.1.5 COMPLEMENTARY TECHNOLOGIES
    • 6.1.5.1 LIS, EHR, and PACS integration
    • 6.1.5.2 Digital biomarker platform
    • 6.1.5.3 Companion diagnostic platforms
    • 6.1.5.4 Telepathology & remote collaboration platforms
  • 6.1.6 ADJACENT TECHNOLOGIES
    • 6.1.6.1 Genomic sequencing
    • 6.1.6.2 Multi-omics platforms
    • 6.1.6.3 Precision medicine platforms
• 6.2 TECHNOLOGY/PRODUCT ROADMAP
• 6.3 PATENT ANALYSIS
  • 6.3.1 PATENT PUBLICATION TRENDS FOR DIGITAL PATHOLOGY MARKET
  • 6.3.2 DIGITAL PATHOLOGY PATENTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 6.4 FUTURE APPLICATIONS
  • 6.4.1 AI-DRIVEN DIAGNOSTIC DECISION SUPPORT
  • 6.4.2 PRECISION MEDICINE & DIGITAL BIOMARKER DEVELOPMENT
  • 6.4.3 INTEGRATED PATHOLOGY FOR DRUG DEVELOPMENT & CLINICAL RESEARCH
• 6.5 IMPACT OF GEN AI IN DIGITAL PATHOLOGY MARKET
  • 6.5.1 INTRODUCTION
  • 6.5.2 MARKET POTENTIAL OF AI/GEN AI IN DIGITAL PATHOLOGY MARKET
  • 6.5.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
    • 6.5.3.1 AI-Powered Computational Pathology for Biomarker Discovery at PathAI
  • 6.5.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
    • 6.5.4.1 AI & computational pathology software market
    • 6.5.4.2 Telepathology & remote collaboration market
    • 6.5.4.3 Digital biomarker market
  • 6.5.5 USER READINESS AND IMPACT ASSESSMENT
    • 6.5.5.1 User readiness
    • 6.5.5.2 Hospitals & health systems
    • 6.5.5.3 Diagnostic & reference laboratories
    • 6.5.5.4 Veterinary laboratories
    • 6.5.5.5 Pharmaceutical & biotechnology companies
    • 6.5.5.6 Contract research organizations (CROs)
    • 6.5.5.7 Academic & research institutes
    • 6.5.5.8 Impact assessment
    • 6.5.5.9 User A: Hospitals and health systems
      • 6.5.5.9.1 Implementation
      • 6.5.5.9.2 Impact
    • 6.5.5.10 User B: Diagnostic & reference laboratories
      • 6.5.5.10.1 Implementation
      • 6.5.5.10.2 Impact
    • 6.5.5.11 User C: Veterinary laboratories
      • 6.5.5.11.1 Implementation
      • 6.5.5.11.2 Impact
    • 6.5.5.12 User D: Pharmaceutical & biotechnology companies
      • 6.5.5.12.1 Implementation
      • 6.5.5.12.2 Impact
    • 6.5.5.13 User E: Contract Research Organizations
      • 6.5.5.13.1 Implementation
      • 6.5.5.13.2 Impact
    • 6.5.5.14 User F: Academic & research institutes
      • 6.5.5.14.1 Implementation
      • 6.5.5.14.2 Impact

7 REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.2 REGULATORY FRAMEWORK
    • 7.1.2.1 North America
    • 7.1.2.2 Europe
    • 7.1.2.3 Asia Pacific
    • 7.1.2.4 Latin America
    • 7.1.2.5 Middle East & Africa
  • 7.1.3 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 INTRODUCTION
• 8.2 DECISION-MAKING PROCESS
• 8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
  • 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.3.2 BUYING CRITERIA
• 8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 8.5.1 UNMET NEEDS
  • 8.5.2 END USER EXPECTATIONS
• 8.6 MARKET PROFITABILITY

9 DIGITAL PATHOLOGY MARKET, BY PRODUCT

• 9.1 INTRODUCTION
• 9.2 HARDWARE
  • 9.2.1 DIGITIZATION OF PATHOLOGY WORKFLOWS AND INCREASING INSTALLATION OF WHOLE-SLIDE IMAGING SYSTEMS TO BOOST MARKET
  • 9.2.2 WHOLE SLIDE IMAGING SCANNERS
    • 9.2.2.1 Increasing pathology workloads & need for remote consultation driving demand
    • 9.2.2.2 Brightfield scanners
      • 9.2.2.2.1 Cost-efficient features to boost demand
    • 9.2.2.3 Fluorescence scanners
      • 9.2.2.3.1 Ability to detect cellular structures and biomarkers to fuel uptake
    • 9.2.2.4 Other scanners
  • 9.2.3 WORKSTATIONS & VIEWING SYSTEMS
    • 9.2.3.1 Rising demand for digital pathology visualization and collaboration tools
  • 9.2.4 PERIPHERALS & ACCESSORIES
    • 9.2.4.1 Growing laboratory automation and workflow digitization support adoption of pathology accessories
• 9.3 SOFTWARE
  • 9.3.1 INCREASING DEMAND FOR REMOTE WORK AND CONSULTATIONS TO BOOST DEMAND
    • 9.3.1.1 Enterprise digital pathology solutions/platforms
      • 9.3.1.1.1 Growing enterprise-wide digital transformation initiatives drive adoption of integrated pathology platforms
    • 9.3.1.2 Image Management Software
      • 9.3.1.2.1 Increasing digital slide volumes drive demand for scalable image management solutions
    • 9.3.1.3 Image analysis software
      • 9.3.1.3.1 Ability to automate quantitative evaluation to support market growth
    • 9.3.1.4 AI & computational pathology software
      • 9.3.1.4.1 Growing adoption of AI-assisted diagnostics drives rapid market expansion
• 9.4 STORAGE SYSTEMS
  • 9.4.1 GROWING FOCUS ON STORAGE OF HIGH-RESOLUTION IMAGES TO DRIVE MARKET
    • 9.4.1.1 On-premise Storage
      • 9.4.1.1.1 Data security, regulatory compliance, and direct infrastructure control support continued adoption
    • 9.4.1.2 Cloud Storage
      • 9.4.1.2.1 Scalability, remote accessibility, and cost-efficient data management driving growth of cloud-based storage solutions
    • 9.4.1.3 Hybrid storage
      • 9.4.1.3.1 Balance of performance, scalability, and compliance requirements accelerate adoption

10 DIGITAL PATHOLOGY MARKET, BY TYPE

• 10.1 INTRODUCTION
• 10.2 HUMAN PATHOLOGY
  • 10.2.1 INCREASING CANCER RESEARCH ACTIVITIES TO PROPEL MARKET
• 10.3 VETERINARY PATHOLOGY
  • 10.3.1 IMPROVEMENTS IN ANIMAL DISEASE DIAGNOSTICS TO SUPPORT MARKET GROWTH

11 DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY

• 11.1 INTRODUCTION
• 11.2 CONVENTIONAL DIGITAL PATHOLOGY
  • 11.2.1 DIGITIZATION OF PATHOLOGY WORKFLOWS AND ADOPTION OF WHOLE-SLIDE IMAGING TECHNOLOGIES DRIVES MARKET
• 11.3 AI-ENABLED DIGITAL PATHOLOGY
  • 11.3.1 ADOPTION OF AI AND COMPUTATIONAL PATHOLOGY TECHNOLOGIES ACCELERATES TRANSITION TO DATA-DRIVEN DIAGNOSTICS

12 DIGITAL PATHOLOGY MARKET, BY APPLICATION

• 12.1 INTRODUCTION
• 12.2 CLINICAL DIAGNOSTICS
  • 12.2.1 INCREASING CANCER INCIDENCE & GROWING ADOPTION OF AI-FOR ASSISTED DIAGNOSTICS TO DRIVE MARKET
• 12.3 PRE-CLINICAL RESEARCH
  • 12.3.1 GROWTH SUPPORTED BY EXPANDING PHARMACEUTICAL AND BIOTECHNOLOGY R&D INVESTMENTS
  • 12.3.2 DRUG DISCOVERY & EFFICACY STUDIES
    • 12.3.2.1 Growing pharmaceutical R&D investments and rising demand for accelerated therapeutic development
  • 12.3.3 TOXICOLOGY AND SAFETY ASSESSMENT
    • 12.3.3.1 Increasing regulatory testing requirements and adoption of AI-enabled pathology analysis for standardized safety evaluations to drive market
  • 12.3.4 BIOMARKER DISCOVERY & VALIDATION
    • 12.3.4.1 Increasing adoption of personalized medicine to boost market
  • 12.3.5 OTHER PRE-CLINICAL RESEARCH
• 12.4 CLINICAL TRIALS
  • 12.4.1 USE FOR CENTRALIZED REVIEW, PATIENT STRATIFICATION, AND BIOMARKER-BASED CLINICAL STUDIES
• 12.5 TELEPATHOLOGY
  • 12.5.1 INCREASING DEMAND FOR REMOTE DIAGNOSTICS AND GROWING SHORTAGE OF PATHOLOGISTS WORLDWIDE TO BOOST GROWTH
• 12.6 ACADEMIC & TRANSLATIONAL RESEARCH
  • 12.6.1 GROWTH SUPPORTED BY EXPANDING COMPUTATIONAL PATHOLOGY RESEARCH AND INVESTMENTS IN PRECISION MEDICINE
• 12.7 EDUCATION & TRAINING
  • 12.7.1 ABILITY TO PROVIDE REAL-TIME LEARNING EXPERIENCES TO SUPPORT MARKET GROWTH
• 12.8 OTHER APPLICATIONS

13 DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA

• 13.1 INTRODUCTION
• 13.2 ONCOLOGY
  • 13.2.1 INCREASING ADOPTION OF PRECISION MEDICINE AND DEMAND FOR AI-ASSISTED CANCER DIAGNOSTICS TO BOOST MARKET
• 13.3 HEMATOLOGY
  • 13.3.1 IMPLEMENTATION OF AI-POWERED SOLUTIONS FOR BONE MARROW AND BLOOD CELL ANALYSIS TO DRIVE MARKET
• 13.4 GASTROINTESTINAL DISEASE
  • 13.4.1 GROWING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS FOR EARLY DISEASE DETECTION AND DIAGNOSIS TO DRIVE MARKET
• 13.5 INFECTIOUS DISEASE
  • 13.5.1 GROWING NEED FOR RAPID AND ACCURATE TISSUE-BASED DIAGNOSTICS TO PROPEL MARKET
• 13.6 NEUROLOGY
  • 13.6.1 GROWING NEED FOR RAPID AND ACCURATE TISSUE-BASED DIAGNOSTICS DRIVES GROWTH
• 13.7 OTHERS THERAPEUTIC AREAS

14 DIGITAL PATHOLOGY MARKET, BY END USER

• 14.1 INTRODUCTION
• 14.2 HOSPITALS & HEALTH SYSTEMS
  • 14.2.1 HIGH INCIDENCE OF INFECTIOUS DISEASES TO BOOST DEMAND
• 14.3 DIAGNOSTICS LABORATORIES & REFERENCE LABORATORIES
  • 14.3.1 INCREASING PUBLIC & PRIVATE FUNDING INVESTMENTS TO SUPPORT MARKET GROWTH
• 14.4 VETERINARY LABORATORIES
  • 14.4.1 TECHNOLOGICAL ADVANCEMENTS IN WHOLE-SLIDE IMAGING SYSTEMS AND AI-POWERED IMAGE ANALYSIS SOFTWARE SUPPORT MARKET GROWTH
• 14.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 14.5.1 INCREASING FOCUS ON DRUG TOXICOLOGY TESTING AND RISING NUMBER OF PRECLINICAL TRIALS TO PROPEL MARKET
• 14.6 CONTRACT RESEARCH ORGANIZATION
  • 14.6.1 DEMAND FOR OUTSOURCED RESEARCH AND BIOMARKER ANALYSIS SUPPORTS ADOPTION
• 14.7 ACADEMIC & RESEARCH INSTITUTES
  • 14.7.1 INCREASING PUBLIC & PRIVATE FUNDING INVESTMENTS TO SUPPORT MARKET GROWTH
• 14.8 OTHER END USERS

15 DIGITAL PATHOLOGY MARKET, BY REGION

• 15.1 INTRODUCTION
• 15.2 NORTH AMERICA
  • 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 15.2.2 US
    • 15.2.2.1 Favorable reimbursements for diagnostics to drive market
  • 15.2.3 CANADA
    • 15.2.3.1 Growing awareness on early cancer detection & diagnosis to drive market
• 15.3 EUROPE
  • 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 15.3.2 GERMANY
    • 15.3.2.1 High healthcare expenditure and supportive research initiatives to drive market
  • 15.3.3 UK
    • 15.3.3.1 Government funding investments for pathology services to fuel market
  • 15.3.4 FRANCE
    • 15.3.4.1 Increasing government funding and favorable insurance system to drive adoption
  • 15.3.5 ITALY
    • 15.3.5.1 Integration of AI & ML to support market growth
  • 15.3.6 SPAIN
    • 15.3.6.1 Supportive collaborations among leading companies and hospitals to boost demand
  • 15.3.7 SWEDEN
    • 15.3.7.1 Increasing prevalence of chronic diseases to support market growth
  • 15.3.8 REST OF EUROPE
• 15.4 ASIA PACIFIC
  • 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 15.4.2 CHINA
    • 15.4.2.1 Increasing establishment of hospitals and reference laboratories to drive market
  • 15.4.3 JAPAN
    • 15.4.3.1 Advanced healthcare infrastructure to support market growth
  • 15.4.4 INDIA
    • 15.4.4.1 High cancer incidence and rapid healthcare digitization supporting strong growth in digital pathology solutions
  • 15.4.5 AUSTRALIA
    • 15.4.5.1 National digital health initiatives and geographically distributed healthcare networks driving demand
  • 15.4.6 SOUTH KOREA
    • 15.4.6.1 Regional leadership in digital pathology and AI diagnostics supporting market expansion
  • 15.4.7 REST OF ASIA PACIFIC
• 15.5 LATIN AMERICA
  • 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 15.5.2 BRAZIL
    • 15.5.2.1 Biopharma clinical trial demand and Conecte SUS integration catalyzing digital pathology infrastructure
  • 15.5.3 MEXICO
    • 15.5.3.1 Private sector healthcare expansion and pharmaceutical manufacturing drive digital pathology adoption
  • 15.5.4 REST OF LATIN AMERICA
• 15.6 MIDDLE EAST & AFRICA
  • 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 15.6.2 GCC COUNTRIES
    • 15.6.2.1 Saudi Arabia
      • 15.6.2.1.1 Vision 2030 health transformation and AI national strategy anchoring pathology digitization investment
    • 15.6.2.2 UAE
      • 15.6.2.2.1 National AI Strategy 2031 and DHA Digital Health Ecosystem positions country as regional pathology hub
    • 15.6.2.3 Other GCC countries
  • 15.6.3 SOUTH AFRICA
    • 15.6.3.1 Growing demand for diagnostic efficiency and healthcare digitalization initiatives to boost market
  • 15.6.4 REST OF MIDDLE EAST & AFRICA

16 COMPETITIVE LANDSCAPE

• 16.1 OVERVIEW
• 16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023-2026
• 16.3 REVENUE ANALYSIS, 2021-2025
• 16.4 MARKET SHARE ANALYSIS, 2025
• 16.5 BRAND COMPARISON
• 16.6 COMPANY VALUATION AND FINANCIAL METRICS
• 16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 16.7.1 STARS
  • 16.7.2 EMERGING LEADERS
  • 16.7.3 PERVASIVE PLAYERS
  • 16.7.4 PARTICIPANTS
  • 16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 16.7.5.1 Company footprint
    • 16.7.5.2 Region footprint
    • 16.7.5.3 Product footprint
    • 16.7.5.4 Application footprint
    • 16.7.5.5 End user footprint
• 16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 16.8.1 PROGRESSIVE COMPANIES
  • 16.8.2 RESPONSIVE COMPANIES
  • 16.8.3 DYNAMIC COMPANIES
  • 16.8.4 STARTING BLOCKS
  • 16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
    • 16.8.5.1 List of startups/SMES
• 16.9 COMPETITIVE SCENARIO
  • 16.9.1 PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS
  • 16.9.2 DEALS
  • 16.9.3 EXPANSIONS
  • 16.9.4 OTHER DEVELOPMENTS

17 COMPANY PROFILES

• 17.1 KEY COMPANIES
  • 17.1.1 DANAHER CORPORATION
    • 17.1.1.1 Business overview
    • 17.1.1.2 Products offered
    • 17.1.1.3 Recent developments
      • 17.1.1.3.1 Product launches & enhancements
      • 17.1.1.3.2 Deals
      • 17.1.1.3.3 Other developments
    • 17.1.1.4 MnM view
      • 17.1.1.4.1 Key strengths
      • 17.1.1.4.2 Strategic choices
      • 17.1.1.4.3 Weaknesses and competitive threats
  • 17.1.2 HOFFMANN-LA ROCHE LTD.
    • 17.1.2.1 Business overview
    • 17.1.2.2 Products offered
    • 17.1.2.3 Recent developments
      • 17.1.2.3.1 Product launches & approvals
      • 17.1.2.3.2 Deals
    • 17.1.2.4 MnM view
      • 17.1.2.4.1 Key strengths
      • 17.1.2.4.2 Strategic choices
      • 17.1.2.4.3 Weaknesses and competitive threats
  • 17.1.3 KONINKLIJKE PHILIPS N.V.
    • 17.1.3.1 Business overview
    • 17.1.3.2 Products offered
    • 17.1.3.3 Recent developments
      • 17.1.3.3.1 Product launches & approvals
      • 17.1.3.3.2 Deals
    • 17.1.3.4 MnM view
      • 17.1.3.4.1 Key strengths
      • 17.1.3.4.2 Strategic choices
      • 17.1.3.4.3 Weaknesses and competitive threats
  • 17.1.4 SECTRA AB
    • 17.1.4.1 Business overview
    • 17.1.4.2 Products offered
    • 17.1.4.3 Recent developments
      • 17.1.4.3.1 Deals
      • 17.1.4.3.2 Other developments
    • 17.1.4.4 MnM view
      • 17.1.4.4.1 Key strengths
      • 17.1.4.4.2 Strategic choices
      • 17.1.4.4.3 Weaknesses and competitive threats
  • 17.1.5 HAMAMATSU PHOTONICS K.K.
    • 17.1.5.1 Business overview
    • 17.1.5.2 Products offered
    • 17.1.5.3 Recent developments
      • 17.1.5.3.1 Deals
    • 17.1.5.4 MnM view
      • 17.1.5.4.1 Key strengths
      • 17.1.5.4.2 Strategic choices
      • 17.1.5.4.3 Weaknesses and competitive threats
  • 17.1.6 QUANTERIX CORPORATION
    • 17.1.6.1 Business overview
    • 17.1.6.2 Products offered
    • 17.1.6.3 Recent developments
      • 17.1.6.3.1 Product launches
    • 17.1.6.4 Recent developments
      • 17.1.6.4.1 Deals
  • 17.1.7 FUJIFILM HOLDINGS CORPORATION
    • 17.1.7.1 Business overview
    • 17.1.7.2 Products offered
    • 17.1.7.3 Recent developments
      • 17.1.7.3.1 Deals
  • 17.1.8 HOLOGIC, INC.
    • 17.1.8.1 Business overview
    • 17.1.8.2 Products offered
    • 17.1.8.3 Recent developments
      • 17.1.8.3.1 Product approvals
  • 17.1.9 3DHISTECH LTD.
    • 17.1.9.1 Business overview
    • 17.1.9.2 Products offered
    • 17.1.9.3 Recent developments
      • 17.1.9.3.1 Product launches & enhancements
      • 17.1.9.3.2 Other developments
  • 17.1.10 APOLLO ENTERPRISE IMAGING CORP.
    • 17.1.10.1 Business overview
    • 17.1.10.2 Products offered
    • 17.1.10.3 Recent developments
      • 17.1.10.3.1 Product enhancements
      • 17.1.10.3.2 Deals
  • 17.1.11 HURON TECHNOLOGIES INTERNATIONAL INC.
    • 17.1.11.1 Business overview
    • 17.1.11.2 Products offered
      • 17.1.11.2.1 Deals
  • 17.1.12 INDICA LABS, LLC.
    • 17.1.12.1 Business overview
    • 17.1.12.2 Products offered
    • 17.1.12.3 Recent developments
      • 17.1.12.3.1 Product launches & approvals
      • 17.1.12.3.2 Deals
  • 17.1.13 OPTRASCAN
    • 17.1.13.1 Business overview
    • 17.1.13.2 Products offered
    • 17.1.13.3 Recent developments
      • 17.1.13.3.1 Product launches & approvals
      • 17.1.13.3.2 Deals
  • 17.1.14 GLENCOE SOFTWARE, INC.
    • 17.1.14.1 Business overview
    • 17.1.14.2 Products offered
    • 17.1.14.3 Recent developments
      • 17.1.14.3.1 Product enhancements
  • 17.1.15 AIFORIA
    • 17.1.15.1 Business overview
    • 17.1.15.2 Products offered
    • 17.1.15.3 Recent developments
      • 17.1.15.3.1 Product launches
      • 17.1.15.3.2 Deals
      • 17.1.15.3.3 Expansions
  • 17.1.16 PAIGE AI, INC.
    • 17.1.16.1 Business overview
    • 17.1.16.2 Products offered
    • 17.1.16.3 Recent developments
      • 17.1.16.3.1 Product launches & enhancements
      • 17.1.16.3.2 Deals
  • 17.1.17 PROSCIA INC.
    • 17.1.17.1 Business overview
    • 17.1.17.2 Products offered
    • 17.1.17.3 Recent developments
      • 17.1.17.3.1 Product enhancements & approvals
      • 17.1.17.3.2 Deals
      • 17.1.17.3.3 Other developments
  • 17.1.18 EVIDENT
    • 17.1.18.1 Business overview
    • 17.1.18.2 Products offered
    • 17.1.18.3 Recent developments
      • 17.1.18.3.1 Product launches
      • 17.1.18.3.2 Deals
• 17.2 OTHER PLAYERS
  • 17.2.1 PATHAI, INC.
  • 17.2.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD.
  • 17.2.3 MIKROSCAN TECHNOLOGIES, INC.
  • 17.2.4 MOTIC DIGITAL PATHOLOGY
  • 17.2.5 MORPHLE LABS INC.
  • 17.2.6 GRUNDIUM OY
  • 17.2.7 CURIOSIS INC.

18 RESEARCH METHODOLOGY

• 18.1 RESEARCH APPROACH
  • 18.1.1 SECONDARY RESEARCH
    • 18.1.1.1 Key data from secondary sources
  • 18.1.2 PRIMARY RESEARCH
    • 18.1.2.1 Key data from primary sources
    • 18.1.2.2 Breakdown of primaries
    • 18.1.2.3 Insights from primary experts
• 18.2 RESEARCH METHODOLOGY DESIGN
• 18.3 MARKET SIZE ESTIMATION
• 18.4 MARKET BREAKDOWN DATA TRIANGULATION
• 18.5 MARKET SHARE ESTIMATION
• 18.6 STUDY ASSUMPTIONS
• 18.7 RESEARCH LIMITATIONS
  • 18.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 18.7.2 SCOPE-RELATED LIMITATIONS
• 18.8 RISK ASSESSMENT

19 APPENDIX

• 19.1 DISCUSSION GUIDE
• 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 19.3 CUSTOMIZATION OPTIONS
• 19.4 RELATED REPORTS
• 19.5 AUTHOR DETAILS

List of Tables

• TABLE 1 EXCHANGE RATES FOR CONVERSION TO USD
• TABLE 2 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
• TABLE 3 HEALTHCARE DATA BREACHES: ENTITIES, IMPACT, AND CAUSES (2025)
• TABLE 4 DIGITAL PATHOLOGY MARKET: PORTER'S FIVE FORCES
• TABLE 5 DIGITAL PATHOLOGY MARKET: ROLE IN ECOSYSTEM
• TABLE 6 INDICATIVE PRICING OF DIGITAL PATHOLOGY PRODUCTS, BY KEY PLAYER (2025)
• TABLE 7 INDICATIVE PRICING OF WHOLE SLIDE IMAGING SCANNERS, BY REGION (2025)
• TABLE 8 IMPORT DATA FOR HS CODE 901180, BY COUNTRY, 2021-2025 (USD THOUSAND)
• TABLE 9 EXPORT DATA FOR HS CODE 901180, BY COUNTRY, 2021-2025 (USD THOUSAND)
• TABLE 10 DIGITAL PATHOLOGY: KEY CONFERENCES & EVENTS, 2026-2027
• TABLE 11 CASE 1: ASSESSING IMAGE QUALITY: A COMPARATIVE MULTI-ASSESSMENT EVALUATION OF APERIO GT 450 DX
• TABLE 12 CASE STUDY 2: HOW TO PROMOTE PATHOLOGY WORKFLOW EFFICIENCY
• TABLE 13 US ADJUSTED RECIPROCAL TARIFF RATES
• TABLE 14 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR DIGITAL PATHOLOGY MARKET
• TABLE 15 DIGITAL PATHOLOGY MARKET: KEY PATENTS/PATENT APPLICATIONS
• TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 21 REGULATORY SCENARIO IN NORTH AMERICA
• TABLE 22 REGULATORY SCENARIO IN EUROPE
• TABLE 23 REGULATORY SCENARIO IN ASIA PACIFIC
• TABLE 24 REGULATORY SCENARIO IN LATIN AMERICA
• TABLE 25 REGULATORY SCENARIO IN MIDDLE EAST & AFRICA
• TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
• TABLE 27 KEY BUYING CRITERIA FOR TOP THREE END USERS
• TABLE 28 UNMET NEEDS IN DIGITAL PATHOLOGY MARKET
• TABLE 29 END USER EXPECTATIONS IN DIGITAL PATHOLOGY MARKET
• TABLE 30 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 31 DIGITAL PATHOLOGY HARDWARE OFFERED BY KEY MARKET PLAYERS
• TABLE 32 DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 33 DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY REGION, 2024-2031(USD MILLION)
• TABLE 34 SCANNING MAGNIFICATION AND APPLICATIONS
• TABLE 35 DIGITAL PATHOLOGY WHOLE SLIDE IMAGING (WSI) SCANNERS OFFERED BY KEY MARKET PLAYERS
• TABLE 36 DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 37 DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 38 BRIGHTFIELD SCANNERS OFFERED BY KEY MARKET PLAYERS
• TABLE 39 DIGITAL PATHOLOGY MARKET FOR BRIGHTFIELD SCANNERS, BY REGION, 2024-2031(USD MILLION)
• TABLE 40 FLUORESCENCE SCANNERS OFFERED BY KEY MARKET PLAYERS
• TABLE 41 DIGITAL PATHOLOGY MARKET FOR FLUORESCENCE SCANNERS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 42 OTHER SCANNERS OFFERED BY KEY MARKET PLAYERS
• TABLE 43 DIGITAL PATHOLOGY MARKET FOR OTHER SCANNERS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 44 WORKSTATIONS & VIEWING SYSTEMS: OFFERED BY KEY MARKET PLAYERS
• TABLE 45 DIGITAL PATHOLOGY MARKET FOR WORKSTATIONS & VIEWING SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 46 PERIPHERALS & ACCESSORIES OFFERED BY KEY MARKET PLAYERS
• TABLE 47 DIGITAL PATHOLOGY MARKET FOR PERIPHERALS & ACCESSORIES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 48 DIGITAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS
• TABLE 49 DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 50 DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
• TABLE 51 ENTERPRISE DIGITAL PATHOLOGY SOLUTIONS/PLATFORMS OFFERED BY KEY MARKET PLAYERS
• TABLE 52 DIGITAL PATHOLOGY MARKET FOR ENTERPRISE DIGITAL PATHOLOGY SOLUTIONS/PLATFORMS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 53 IMAGE MANAGEMENT SOFTWARE OFFERED BY KEY MARKET PLAYERS
• TABLE 54 DIGITAL PATHOLOGY MARKET FOR IMAGE MANAGEMENT SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
• TABLE 55 IMAGE ANALYSIS SOFTWARE OFFERED BY KEY MARKET PLAYERS
• TABLE 56 DIGITAL PATHOLOGY MARKET FOR IMAGE ANALYSIS SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
• TABLE 57 AI & COMPUTATIONAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS
• TABLE 58 DIGITAL PATHOLOGY MARKET FOR AI & COMPUTATIONAL PATHOLOGY SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
• TABLE 59 DIGITAL PATHOLOGY STORAGE SYSTEMS OFFERED BY KEY MARKET PLAYERS
• TABLE 60 DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 61 DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 62 DIGITAL PATHOLOGY MARKET FOR ON-PREMISE STORAGE, BY REGION, 2024-2031 (USD MILLION)
• TABLE 63 DIGITAL PATHOLOGY MARKET FOR CLOUD STORAGE, BY REGION, 2024-2031 (USD MILLION)
• TABLE 64 DIGITAL PATHOLOGY MARKET FOR HYBRID STORAGE, BY REGION, 2024-2031 (USD MILLION)
• TABLE 65 DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 66 DIGITAL PATHOLOGY MARKET FOR HUMAN DIGITAL PATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
• TABLE 67 DIGITAL PATHOLOGY MARKET FOR VETERINARY DIGITAL PATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
• TABLE 68 DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 69 DIGITAL PATHOLOGY MARKET FOR CONVENTIONAL DIGITAL PATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
• TABLE 70 DIGITAL PATHOLOGY MARKET FOR AI-ENABLED DIGITAL PATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
• TABLE 71 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 72 DIGITAL PATHOLOGY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 73 DIGITAL PATHOLOGY MARKET, BY PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 74 DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY REGION, 2024-2031 (USD MILLION)
• TABLE 75 DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY & EFFICACY STUDIES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 76 DIGITAL PATHOLOGY MARKET FOR TOXICOLOGY AND SAFETY ASSESSMENT, BY REGION, 2024-2031 (USD MILLION)
• TABLE 77 DIGITAL PATHOLOGY MARKET FOR BIOMARKER DISCOVERY AND VALIDATION, BY REGION, 2024-2031 (USD MILLION)
• TABLE 78 DIGITAL PATHOLOGY MARKET OTHER PRE-CLINICAL RESEARCH, BY REGION, 2024-2031 (USD MILLION)
• TABLE 79 DIGITAL PATHOLOGY MARKET FOR CLINICAL TRIALS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 80 DIGITAL PATHOLOGY MARKET FOR TELEPATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
• TABLE 81 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & TRANSLATIONAL RESEARCH, BY REGION, 2024-2031 (USD MILLION)
• TABLE 82 DIGITAL PATHOLOGY MARKET FOR EDUCATION & TRAINING, BY REGION, 2024-2031 (USD MILLION)
• TABLE 83 DIGITAL PATHOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 84 DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 85 DIGITAL PATHOLOGY MARKET FOR ONCOLOGY, BY REGION, 2024-2031 (USD MILLION)
• TABLE 86 DIGITAL PATHOLOGY MARKET FOR HEMATOLOGY, BY REGION, 2024-2031 (USD MILLION)
• TABLE 87 DIGITAL PATHOLOGY MARKET FOR GASTROINTESTINAL DISEASE, BY REGION, 2024-2031 (USD MILLION)
• TABLE 88 DIGITAL PATHOLOGY MARKET FOR INFECTIOUS DISEASE, BY REGION, 2024-2031 (USD MILLION)
• TABLE 89 DIGITAL PATHOLOGY MARKET FOR NEUROLOGY, BY REGION, 2024-2031 (USD MILLION)
• TABLE 90 DIGITAL PATHOLOGY MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 91 DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 92 DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS & HEALTH SYSTEMS
• TABLE 93 DIGITAL PATHOLOGY MARKET FOR HOSPITALS & HEALTH SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 94 DIGITAL PATHOLOGY MARKET FOR DIAGNOSTICS & REFERENCE LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 95 DIGITAL PATHOLOGY MARKET FOR VETERINARY LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 96 DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 97 DIGITAL PATHOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 98 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 99 DIGITAL PATHOLOGY MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 100 DIGITAL PATHOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
• TABLE 101 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 102 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 103 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 104 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 105 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031(USD MILLION)
• TABLE 106 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031(USD MILLION)
• TABLE 107 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 108 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 109 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 110 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 111 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 112 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 113 CAT III - DIGITAL PATHOLOGY ADD-ON CPT CODES - EFFECTIVE 1 JANUARY 2024
• TABLE 114 US: CANCER INCIDENCE, BY CANCER TYPE, 2022 VS. 2040
• TABLE 115 US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 116 US: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 117 US: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 118 US: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031(USD MILLION)
• TABLE 119 US: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031(USD MILLION)
• TABLE 120 US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 121 US: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 122 US: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 123 US: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 124 US: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 125 US: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 126 CANADA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
• TABLE 127 CANADA: FUNDING INITIATIVES FOR DIGITAL PATHOLOGY
• TABLE 128 CANADA: KEY MACROINDICATORS
• TABLE 129 CANADA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 130 CANADA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 131 CANADA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 132 CANADA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031(USD MILLION)
• TABLE 133 CANADA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031(USD MILLION)
• TABLE 134 CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 135 CANADA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 136 CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 137 CANADA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 138 CANADA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 139 CANADA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 140 EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 141 EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 142 EUROPE: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 143 EUROPE: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 144 EUROPE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 145 EUROPE: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 146 EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 147 EUROPE: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 148 EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 149 EUROPE: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 150 EUROPE: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 151 EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 152 GERMANY: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
• TABLE 153 GERMANY: KEY MACROINDICATORS
• TABLE 154 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 155 GERMANY: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 156 GERMANY: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 157 GERMANY: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 158 GERMANY: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 159 GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 160 GERMANY: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 161 GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 162 GERMANY: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 163 GERMANY: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 164 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 165 UK: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
• TABLE 166 UK: KEY MACROINDICATORS
• TABLE 167 UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 168 UK: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 169 UK: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 170 UK: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 171 UK: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 172 UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 173 UK: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 174 UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 175 UK: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 176 UK: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 177 UK: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 178 FRANCE: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
• TABLE 179 FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 180 FRANCE: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 181 FRANCE: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 182 FRANCE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 183 FRANCE: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 184 FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 185 FRANCE: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 186 FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 187 FRANCE: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 188 FRANCE: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 189 FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 190 ITALY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 191 ITALY: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 192 ITALY: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 193 ITALY: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 194 ITALY: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 195 ITALY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 196 ITALY: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 197 ITALY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 198 ITALY: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 199 ITALY: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 200 ITALY: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 201 SPAIN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 202 SPAIN: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 203 SPAIN: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 204 SPAIN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 205 SPAIN: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 206 SPAIN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 207 SPAIN: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 208 SPAIN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 209 SPAIN: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 210 SPAIN: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 211 SPAIN: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 212 SWEDEN: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
• TABLE 213 SWEDEN: KEY MACROINDICATORS
• TABLE 214 SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 215 SWEDEN: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 216 SWEDEN: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 217 SWEDEN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 218 SWEDEN: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 219 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 220 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 221 SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 222 SWEDEN: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 223 SWEDEN: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 224 SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 225 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 226 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 227 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 228 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 229 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 230 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 231 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 232 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 233 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 234 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 235 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 236 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 237 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 238 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 239 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 240 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 241 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 242 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 243 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 244 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 245 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 246 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 247 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 248 CHINA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
• TABLE 249 CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 250 CHINA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 251 CHINA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 252 CHINA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 253 CHINA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 254 CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 255 CHINA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 256 CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 257 CHINA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 258 CHINA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 259 CHINA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 260 JAPAN: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
• TABLE 261 JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 262 JAPAN: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 263 JAPAN: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 264 JAPAN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 265 JAPAN: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 266 JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 267 JAPAN: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 268 JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 269 JAPAN: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 270 JAPAN: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 271 JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 272 INDIA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
• TABLE 273 INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 274 INDIA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 275 INDIA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 276 INDIA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 277 INDIA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 278 INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 279 INDIA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 280 INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 281 INDIA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 282 INDIA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 283 INDIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 284 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 285 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 286 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 287 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 288 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 289 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 290 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 291 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 292 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 293 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 294 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 295 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 296 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 297 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 298 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 299 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 300 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 301 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 302 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 303 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 304 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 305 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 306 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 307 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 308 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 309 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 310 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 311 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 312 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 313 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 314 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 315 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 316 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 317 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 318 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 319 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 320 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 321 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 322 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 323 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 324 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 325 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 326 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 327 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 328 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 329 BRAZIL: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
• TABLE 330 BRAZIL: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 331 BRAZIL: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 332 BRAZIL: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 333 BRAZIL: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 334 BRAZIL: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 335 BRAZIL: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 336 BRAZIL: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 337 BRAZIL: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 338 BRAZIL: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 339 BRAZIL: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 340 BRAZIL: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 341 MEXICO: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
• TABLE 342 MEXICO: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 343 MEXICO: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 344 MEXICO: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 345 MEXICO: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 346 MEXICO: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 347 MEXICO: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 348 MEXICO: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 349 MEXICO: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 350 MEXICO: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 351 MEXICO: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 352 MEXICO: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 353 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 354 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 355 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 356 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 357 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 358 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 359 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 360 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 361 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 362 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 363 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 364 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 365 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 366 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 367 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 368 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 369 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 370 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 371 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 372 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 373 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 374 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 375 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 376 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 377 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 378 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 379 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 380 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 381 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 382 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 383 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 384 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 385 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 386 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 387 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 388 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 389 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 390 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 391 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 392 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 393 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 394 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 395 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 396 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 397 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 398 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 399 UAE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 400 UAE: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 401 UAE: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 402 UAE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 403 UAE: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 404 UAE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 405 UAE: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 406 UAE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 407 UAE: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 408 UAE: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 409 UAE: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 410 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 411 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 412 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 413 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 414 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 415 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 416 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 417 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 418 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 419 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 420 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 421 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 422 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 423 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 424 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 425 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 426 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 427 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 428 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 429 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 430 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 431 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 432 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 433 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 434 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 435 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 436 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 437 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 438 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
• TABLE 439 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 440 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 441 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
• TABLE 442 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 443 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023-2026
• TABLE 444 DIGITAL PATHOLOGY MARKET: DEGREE OF COMPETITION
• TABLE 445 DIGITAL PATHOLOGY MARKET: REGION FOOTPRINT
• TABLE 446 DIGITAL PATHOLOGY MARKET: PRODUCT FOOTPRINT
• TABLE 447 DIGITAL PATHOLOGY MARKET: APPLICATION FOOTPRINT
• TABLE 448 DIGITAL PATHOLOGY MARKET: END USER FOOTPRINT
• TABLE 449 LIST OF STARTUPS/SMES
• TABLE 450 DIGITAL PATHOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
• TABLE 451 DIGITAL PATHOLOGY MARKET: PRODUCT LAUNCHES, ENHANCEMENTS, APPROVALS 2023-2026
• TABLE 452 DIGITAL PATHOLOGY MARKET: DEALS, 2023-2026
• TABLE 453 DIGITAL PATHOLOGY MARKET: EXPANSIONS, 2023-2026
• TABLE 454 DIGITAL PATHOLOGY MARKET: OTHER DEVELOPMENTS, 2023-2026
• TABLE 455 DANAHER CORPORATION: COMPANY OVERVIEW
• TABLE 456 DANAHER CORPORATION: PRODUCTS OFFERED
• TABLE 457 DANAHER CORPORATION: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2023-JUNE 2026
• TABLE 458 DANAHER CORPORATION: DEALS, JANUARY 2023-JUNE 2026
• TABLE 459 DANAHER CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
• TABLE 460 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
• TABLE 461 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
• TABLE 462 HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
• TABLE 463 HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2023-JUNE 2026
• TABLE 464 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
• TABLE 465 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
• TABLE 466 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
• TABLE 467 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023-JUNE 2026
• TABLE 468 SECTRA AB: COMPANY OVERVIEW
• TABLE 469 SECTRA AB: PRODUCTS OFFERED
• TABLE 470 SECTRA AB: DEALS, JANUARY 2023-JUNE 2026
• TABLE 471 SECTRA AB: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
• TABLE 472 HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW
• TABLE 473 HAMAMATSU PHOTONICS K.K.: PRODUCTS OFFERED
• TABLE 474 HAMAMATSU PHOTONICS K.K.: DEALS, JANUARY 2023-JUNE 2026
• TABLE 475 QUANTERIX CORPORATION: COMPANY OVERVIEW
• TABLE 476 QUANTERIX CORPORATION: PRODUCTS OFFERED
• TABLE 477 QUANTERIX CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
• TABLE 478 QUANTERIX CORPORATION :DEALS, JANUARY 2023-JUNE 2026
• TABLE 479 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
• TABLE 480 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
• TABLE 481 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2023-JUNE 2026
• TABLE 482 HOLOGIC, INC.: COMPANY OVERVIEW
• TABLE 483 HOLOGIC, INC: PRODUCTS OFFERED
• TABLE 484 HOLOGIC, INC: PRODUCT APPROVALS, JANUARY 2023-JUNE 2026
• TABLE 485 3DHISTECH LTD.: COMPANY OVERVIEW
• TABLE 486 3DHISTECH LTD.: PRODUCTS OFFERED
• TABLE 487 3DHISTECH LTD.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2023-JUNE 2026
• TABLE 488 3DHISTECH LTD.: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
• TABLE 489 APOLLO ENTERPRISE IMAGING CORP.: COMPANY OVERVIEW
• TABLE 490 APOLLO ENTERPRISE IMAGING CORP.: PRODUCTS OFFERED
• TABLE 491 APOLLO ENTERPRISE IMAGING CORP.: PRODUCT ENHANCEMENTS, JANUARY 2023-JUNE 2026
• TABLE 492 APOLLO ENTERPRISE IMAGING CORP.: DEALS, JANUARY 2023-JUNE 2026
• TABLE 493 HURON TECHNOLOGIES INTERNATIONAL INC.: COMPANY OVERVIEW
• TABLE 494 HURON TECHNOLOGIES INTERNATIONAL INC.: PRODUCTS OFFERED
• TABLE 495 HURON TECHNOLOGIES INTERNATIONAL INC.: DEALS, JANUARY 2023-JUNE 2026
• TABLE 496 HURON TECHNOLOGIES INTERNATIONAL INC.: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
• TABLE 497 INDICA LABS, LLC.: COMPANY OVERVIEW
• TABLE 498 INDICA LABS, LLC: PRODUCTS OFFERED
• TABLE 499 INDICA LABS, LLC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
• TABLE 500 INDICA LABS, LLC.: DEALS, JANUARY 2023-JUNE 2026
• TABLE 501 INDICA LABS, LLC.: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
• TABLE 502 OPTRASCAN: COMPANY OVERVIEW
• TABLE 503 OPTRASCAN: PRODUCTS OFFERED
• TABLE 504 OPTRASCAN: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
• TABLE 505 OPTRASCAN: DEALS, JANUARY 2023-JUNE 2026
• TABLE 506 GLENCOE SOFTWARE, INC.: COMPANY OVERVIEW
• TABLE 507 GLENCOE SOFTWARE, INC.: PRODUCTS OFFERED
• TABLE 508 GLENCOE SOFTWARE, INC.: PRODUCT ENHANCEMENTS, JANUARY 2023-JUNE 2026
• TABLE 509 AIFORIA: COMPANY OVERVIEW
• TABLE 510 AIFORIA: PRODUCTS OFFERED
• TABLE 511 AIFORIA: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
• TABLE 512 AIFORIA: DEALS, JANUARY 2023-JUNE 2026
• TABLE 513 AIFORIA: EXPANSIONS, JANUARY 2023-JUNE 2026
• TABLE 514 PAIGE AI, INC.: COMPANY OVERVIEW
• TABLE 515 PAIGE AI, INC.: PRODUCTS OFFERED
• TABLE 516 PAIGE AI, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2023-JUNE 2026
• TABLE 517 PAIGE AI, INC.: DEALS, JANUARY 2023-JUNE 2026
• TABLE 518 PROSCIA INC.: COMPANY OVERVIEW
• TABLE 519 PROSCIA INC.: PRODUCTS OFFERED
• TABLE 520 PROSCIA INC.: PRODUCT ENHANCEMENTS & APPROVALS, JANUARY 2023-JUNE 2026
• TABLE 521 PROSCIA INC.: DEALS, JANUARY 2023-JUNE 2026
• TABLE 522 PROSCIA INC.: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
• TABLE 523 EVIDENT: COMPANY OVERVIEW
• TABLE 524 EVIDENT: PRODUCTS OFFERED
• TABLE 525 EVIDENT: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
• TABLE 526 EVIDENT: DEALS, JANUARY 2023-JUNE 2026
• TABLE 527 RISK ASSESSMENT: DIGITAL PATHOLOGY MARKET

List of Figures

• FIGURE 1 MARKET SCENARIO
• FIGURE 2 GLOBAL DIGITAL PATHOLOGY MARKET, 2024-2031
• FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL PATHOLOGY MARKET, 2023-2026
• FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF DIGITAL PATHOLOGY MARKET
• FIGURE 5 HIGH-GROWTH SEGMENTS IN DIGITAL PATHOLOGY MARKET, 2026-2031
• FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN DIGITAL PATHOLOGY MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
• FIGURE 7 RISING PREVALENCE OF CANCER AND OTHER CHRONIC DISEASES IS INCREASING PATHOLOGY TESTING VOLUME TO DRIVE MARKET GROWTH
• FIGURE 8 HARDWARE IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
• FIGURE 9 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• FIGURE 10 DIGITAL PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 11 GLOBAL CANCER INCIDENCE, 2008-2030
• FIGURE 12 FDA-APPROVED PERSONALIZED MEDICINES, 2015-2024
• FIGURE 13 DIGITAL PATHOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 14 DIGITAL PATHOLOGY MARKET: VALUE CHAIN ANALYSIS
• FIGURE 15 ECOSYSTEM ANALYSIS
• FIGURE 16 REVENUE SHIFT IN DIGITAL PATHOLOGY MARKET
• FIGURE 17 RECENT FUNDING OF PLAYERS IN DIGITAL PATHOLOGY MARKET
• FIGURE 18 PATENT PUBLICATION TRENDS IN DIGITAL PATHOLOGY MARKET, 2015-2026
• FIGURE 19 JURISDICTION AND TOP APPLICANT ANALYSIS FOR DIGITAL PATHOLOGY MARKET
• FIGURE 20 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR DIGITAL PATHOLOGY MARKET (JANUARY 2015-JUNE 2026)
• FIGURE 21 MARKET POTENTIAL OF GENERATIVE AI IN ENHANCING DIGITAL PATHOLOGY
• FIGURE 22 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEM
• FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
• FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS
• FIGURE 25 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT
• FIGURE 26 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET SNAPSHOT
• FIGURE 27 DIGITAL PATHOLOGY MARKET: REVENUE ANALYSIS OF TOP LISTED/PUBLIC PLAYERS, 2021-2025 (USD MILLION)
• FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
• FIGURE 29 BRAND COMPARISON
• FIGURE 30 EV/EBITDA OF KEY VENDORS
• FIGURE 31 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 32 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
• FIGURE 33 DIGITAL PATHOLOGY MARKET: COMPANY FOOTPRINT
• FIGURE 34 COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
• FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
• FIGURE 36 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
• FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
• FIGURE 38 SECTRA AB: COMPANY SNAPSHOT (2025)
• FIGURE 39 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2025)
• FIGURE 40 AKOYA BIOSCIENCES, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 41 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025)
• FIGURE 42 HOLOGIC, INC.: COMPANY SNAPSHOT (2025)
• FIGURE 43 RESEARCH DESIGN
• FIGURE 44 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 45 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
• FIGURE 46 BOTTOM-UP APPROACH
• FIGURE 47 TOP-DOWN APPROACH
• FIGURE 48 CAGR PROJECTIONS FROM DROC ANALYSIS OF DIGITAL PATHOLOGY MARKET
• FIGURE 49 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• FIGURE 50 DATA TRIANGULATION METHODOLOGY